💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Here are the big winners on Wall Street from Bayer's $62 billion bid for Monsanto

Published 05/23/2016, 10:27 AM
Updated 05/23/2016, 11:00 AM
© REUTERS/Tomas Bravo
BAC
-
CSGN
-
BAYGN
-
MS
-
MON
-

The German pharmaceutical giant Bayer (DE:BAYGN) has made a $62 billion bid for the US seed company Monsanto (NYSE:MON) — and five banks stand to make nearly $500 million from the deal.

Morgan Stanley (NYSE:MS), Ducera Partners, Credit Suisse (SIX:CSGN), Bank of America Merrill Lynch (NYSE:BAC), and Rothschild are advising on the deal, which would be the largest takeover by a German company on record.

It would also create the world's largest farm supplier.

Morgan Stanley and the boutique bank Ducera are advising Monsanto, and are expected to split $100-$110 million in advisory fees, according to the consultant Freeman & Co.

Ducera partners Michael Kramer, Derron Slonecker, Joshua Scherer, and Adam Verost were the lead advisers for that bank.

Credit Suisse, Bank of America, and Rothschild are advising Bayer, and are expected to split $70-80 million in advisory fees. The majority of that will likely go to the two bulge-bracket banks.

Financing fees are expected to make up 0.3-0.5% of the debt capital raised, according to Freeman. Assuming that 75% of the $62 billion bid is financed with debt, the fees could be up to $200 million.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.